STOCK COMPENSATION PLANS (Details) (USD $) In Millions, except Share data, unless otherwise specified
|
12 Months Ended |
|
12 Months Ended |
|
3 Months Ended |
12 Months Ended |
3 Months Ended |
12 Months Ended |
|
12 Months Ended |
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
Dec. 31, 2011
2010-2012 Performance Period
|
Dec. 31, 2011
2011-2013 Performace Period
|
Dec. 31, 2011
CCE's North American business
|
Dec. 31, 2010
CCE's North American business
|
Dec. 31, 2010
CCE's North American business
Performance Period 2008-2010, 2009 and 2010
|
Dec. 31, 2011
CCE's North American business
Performance Period 2008-2010 and 2010
|
Dec. 31, 2010
CCE's North American business
Performance Period 2008-2010 and 2010
|
Dec. 31, 2010
CCE's North American business
2009 Performance Period
|
Dec. 31, 2010
CCE's North American business
2009 Performance Period
|
Dec. 31, 2011
CCE's North American business
CCE 2007 Performance Grants
|
Dec. 31, 2011
1999 Option Plan
|
Dec. 31, 2011
2002 Option Plan
|
Dec. 31, 2011
2008 Option Plan
|
Dec. 31, 2011
Stock options granted in December 2003 and thereafter
|
Dec. 31, 2011
Stock options granted from 1999 through July 2003
|
Dec. 31, 2011
Performance share units
|
Dec. 31, 2011
Performance share units
2008-2010 Performance Period
|
Dec. 31, 2011
Restricted stock
|
Dec. 31, 2011
1989 Restricted Stock Award Plan
|
Dec. 31, 2011
1983 Restricted Stock Award Plan
|
Dec. 31, 2011
Time-Based Restricted Stock Unit Awards
|
Dec. 31, 2011
Time-Based Restricted Stock Unit Awards
CCE's North American business
|
Dec. 31, 2011
Performance-based Restricted Stock Unit Awards
|
STOCK COMPENSATION PLANS [Abstract] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense |
$ 354
|
$ 380
|
$ 241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements |
99
|
110
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted |
516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years) |
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation arrangement by share based payment award equity instruments other than options outstanding and nonvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,500
|
|
|
|
|
|
Vesting period of stock-based awards (in years) |
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average assumptions used in the Black Scholes Merton option pricing model |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of options at grant date (in dollars per share) |
$ 9.28
|
$ 9.39
|
$ 6.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield (as a percent) |
2.70%
|
2.90%
|
3.40%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility (as a percent) |
19.00%
|
20.00%
|
20.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate (as a percent) |
2.30%
|
3.00%
|
2.80%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term of the option (in years) |
5
|
6
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation disclosure |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock was approved to be issued or transferred through the grant of stock options (in shares) |
90,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
120,000,000
|
120,000,000
|
140,000,000
|
|
|
|
|
|
40,000,000
|
24,000,000
|
|
|
|
Outstanding on January 1, 2011 (in shares) |
171,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (in shares) |
26,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised (in shares) |
(32,000,000)
|
(37,000,000)
|
(15,000,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited/expired (in shares) |
(3,000,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on December 31, 2011 (in shares) |
162,000,000
|
171,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to vest at December 31, 2011 (in shares) |
160,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable on December 31, 2011 (in shares) |
106,000,000
|
|
|
|
|
3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on January 1, 2011, Weighted-Average Exercise Price (in dollars per share) |
$ 48.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted, Weighted-Average Exercise Price (in dollars per share) |
$ 64.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised, Weighted-Average Exercise Price (in dollars per share) |
$ 47.96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share) |
$ 53.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on December 31. 2011, Weighted-Average Exercise Price (in dollars per share) |
$ 51.23
|
$ 48.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to vest at December 31, 2011, Weighted-Average Exercise Price (in dollars per share) |
$ 51.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable on December 31, 2011, Weighted-Average Exercise Price (in dollars per share) |
$ 48.65
|
|
|
|
|
$ 36.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on December 31, 2011, Weighted-Average Remaining Contractual Life (in years) |
5.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to vest at December 31, 2011, Weighted-Average Remaining Contractual Life (in years) |
5.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable on December 31, 2011, Weighted-Average Remaining Contractual Life (in years) |
4.76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on December 31, 2011, Aggregate Intrinsic Value (in dollars) |
3,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to vest at December 31, 2011, Aggregate Intrinsic Value (in dollars) |
3,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable on December 31, 2011, Aggregate Intrinsic Value (in dollars) |
2,266
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration period of stock-based awards (in years) |
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
10
|
15
|
|
|
|
|
|
|
|
|
Total intrinsic value of options exercised during the year |
631
|
524
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares Available for Grant |
|
|
|
|
|
14,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,000,000
|
|
|
|
|
|
Summary disclosures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding on January 1, 2011 (in shares) |
|
|
|
2,716,000
|
2,967,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,254,000
|
|
|
|
|
367,000
|
309,000
|
130,000
|
Conversion to Restricted Stock Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,311,000)
|
|
|
|
|
|
|
|
Paid in cash equivalent (in shares) |
(9,731)
|
(13,825)
|
(20,958)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,000)
|
|
|
|
|
|
|
|
Canceled/forfeited (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(304,000)
|
|
(17,000)
|
|
|
|
|
|
Outstanding on December 31, 2011 (in shares) |
|
|
|
2,716,000
|
2,967,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,683,000
|
|
|
|
|
367,000
|
309,000
|
130,000
|
Outstanding on January 1, 2011, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 51.60
|
|
$ 43.29
|
|
|
|
|
|
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
$ 59.12
|
|
|
|
|
|
|
|
|
|
|
$ 51.16
|
|
$ 53.08
|
|
|
|
|
|
Convertion to restricted Stock in Period Weighted Average Grant Date Fair Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 53.08
|
|
|
|
|
|
|
|
Paid in cash equivalent, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 53.13
|
|
|
|
|
|
|
|
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 50.56
|
|
$ 43.71
|
|
|
|
|
|
Outstanding on December 31, 2011, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 50.81
|
|
$ 53.05
|
|
|
|
|
|
Novested at target on January 1, 2011 (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
797,000
|
|
|
|
|
|
Vested and released (in shares) |
(1,023,597)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,024,000)
|
|
|
|
|
|
Restricted shares units vested and released (in shares) |
(1,042,456)
|
(925,233)
|
(1,269,604)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested at target on December 31, 2011 (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,067,000
|
|
|
|
|
|
Vested and released, Weighted-Average Grant-Date Fair Value (in dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 45.72
|
|
|
|
|
|
Number of shares issued due to modification in the performance awards |
|
|
|
|
|
|
|
|
1,500,000
|
|
1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual payout (in percent) |
|
|
|
|
|
|
|
|
|
|
200.00%
|
200.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intrinsic value of shares issued due to modification in the performance awards |
|
|
|
|
|
|
|
|
|
98
|
|
91
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding performance share units at the Threshold Award Level (in shares) |
2,800,000
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding performance share units at the Maximum Award Level (in shares) |
8,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance share awards paid in cash equivalent, value |
0.7
|
0.7
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance period for determining the number of shares earned by an employee, low end of the range (in years) |
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance period for determining number of shares earned by employee, high end of the range (in years) |
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum percentage of target up to which additional shares may be granted (as a percent) |
|
|
|
|
|
|
|
|
|
|
|
|
200.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected payout (as a percent) |
|
|
|
|
|
|
|
|
|
200.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated Share-based Compensation Expense |
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares vested and released under performance share unit awards, total intrinsic value |
$ 72
|
$ 58
|
$ 66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
|
|
|
|
|
|
1,600,000
|
|
|
|
|
|
|
|
|
|
|
3,054,000
|
173,360
|
2,311,000
|
|
|
|
|
|